A novel treatment for glioblastoma, consisting of a combination of an oncolytic virus, engineered to selectively infect and kill cancer cells, and type of a targeted immunotherapy called immune checkpoint inhibition, is showing promise, prolonging patient survival. Read the article from the University of Toronto here.
clinical trials
New Immunotherapy Clinical Trial
A new clinical trial using immunotherapy is taking place at the National Hospital for Neurology and Neurosurgery in Bloomsbury. It is said that, “This is the most important trial for brain cancer patients in the last 15 years.” Read more.
Clinical Trial Recruiting Patients
The Center for Neuro-Oncology at the Dana-Farber Cancer Institute in Boston is recruiting newly diagnosed patients for a clinical trial using three new drugs. They are hoping that these drugs will improve survival for patients with glioblastoma. For more information follow this link.